Rates of diagnosis for depression fell by 27.7% after the COVID-19 pandemic, compared with pre-pandemic rates, according to ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved zuranolone (Zurzuvae, Biogen) for treating moderate-to-severe postnatal depression (PND) in adults following childbirth.

Depression could be an early warning sign that may appear up to eight years before a diagnosis of Parkinson's disease or Lewy body dementia ...

Different types of depression affect the body in different ways. Atypical, energy-related depression raises the risk of diabetes, while melancholic depression increases the likelihood of heart disease ...

No single ‘depression gene’ has been found, but large studies have identified over 100 genetic risk markers on chromosomes ...